CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Ampigrin Ultra Forte Night

Acetaminophen· ingredient acetaminophenAminoalkyl ethers· ACETAMINOPHEN 325 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 15 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.12029
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other acetaminophen products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
Acetaminophen Oral Solution$0.01218−$0.10810
Basic Care Daytime Cold and Flu$0.01348−$0.10680
24-7 Life BY 7-ELEVEN Nighttime Cold and Flu$0.01504−$0.10520
Acetaminophen Extra Strength$0.01901−$0.10130
ADWE Childrens Pain Fever$0.02109−$0.09920
basic care tussin cf severe$0.02410−$0.09620
Acetaminophen 325mg$0.02520−$0.09510
365 whole foods market acetaminophen$0.03423−$0.08610

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.